Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

M2-like tumor-associated macrophages (TAM) are associated with tumor progression and poor prognosis in cancer. This protocol serves as a detailed guide to reproducibly differentiate and polarize THP-1 monocyte-like cells into M2-like macrophages within 14 days. This model is the basis to investigate the anti-inflammatory effects of TAM within the tumor microenvironment.

Abstract

Tumor-associated macrophages (TAM) can switch their expression and cytokine profile according to external stimuli. This remarkable plasticity enables TAM to adapt to ongoing changes within the tumor microenvironment. Macrophages can have either primarily pro-inflammatory (M1-like) or anti-inflammatory (M2-like) attributes and can continually switch between these two main states. M2-like macrophages within the tumor environment are associated with cancer progression and poor prognosis in several types of cancer. Many different methods for inducing differentiation and polarization of THP-1 cells are used to investigate cellular and intercellular mechanisms and the effects of TAM within the microenvironment of tumors. Currently, there is no established model for M2-like macrophage polarization using the THP-1 cell line, and the results of expression and cytokine profiles of macrophages due to certain in vitro stimuli vary between studies. This protocol serves as detailed guidance to differentiate THP-1 monocyte-like cells into M0 macrophages and to further polarize cells into an M2-like phenotype within 14 days. We demonstrate the morphological changes of THP-1 monocyte-like cells, differentiated macrophages, and polarized M2-like macrophages using light microscopy. This model is the basis for cell line models investigating the anti-inflammatory effects of TAM and their interactions with other cell populations of the tumor microenvironment.

Introduction

Tumor-associated macrophages (TAM) and their role in chronic inflammation, the onset of cancer, and tumor development are important targets in recent research1,2. Peripheral blood monocytes that are recruited to the tissue microenvironment of the developing tumor differentiate into macrophages and can be polarized into two main subtypes of macrophages3. The classically activated macrophage represents the primarily pro-inflammatory M1-like phenotype and the alternatively activated M2-like subtype shows predominantly anti-inflammatory characteristics4. Macrophages can switch dynamically between these two main phenotypes depending upon their cellular metabolism, with intermediate subtypes having both inflammatory and anti-inflammatory attributes5. TAM represents a heterogeneous population of both phenotypes. A tumor-promoting function and poor prognosis in different types of cancers is, however, particularly associated with M2-like macrophages6,7,8.

The functional profiles of macrophages and their interaction with other cells within the tumor microenvironment are complex and challenging to capture in a continuously changing environment during ongoing tumor development. Cell lines can provide a homogenous cell population with stable viability in culture, which can facilitate the process of demonstrating defined cellular and intercellular mechanisms. The monocyte-like THP-1 cell line is a legitimate model system for primary human monocytes9. This spontaneously immortalized cell line has been obtained from the peripheral blood of a one-year-old infant with acute monocytic leukemia9,10. The differentiation and polarization of THP-1 cells have been reported by several studies and have been performed in multiple different ways11,12,13,14. Activation and, therefore, the polarization of macrophages into an M1-like phenotype is followed by a compensatory anti-inflammatory rebound mechanism, promoting an M2-like phenotype through cytokines produced by inflammatory macrophages, such as interleukin 6 (IL-6) or itaconate15,16. This might serve as a break mechanism to attenuate an overshooting inflammatory response following cell activation17. The process of differentiating and polarizing monocytes and THP-1 monocyte-like cells into an anti-inflammatory M2-like phenotype is itself also accompanied by pro-inflammatory stimuli that must be overcome. An inflammatory cytokine response can be caused by mechanical stress18, such as changing media to refeed the cells, or adding chemical compounds to differentiate THP-1 cells, such as phorbol 12-myristate 13-acetate (PMA), and induce production of tumor necrosis factor α (TNFα), interleukin 1β (IL-1β) or IL-619. This altered cytokine expression profile as a response to PMA can affect and prevent subsequent macrophage polarization20. Adequate resting periods, as reported before after PMA treatment, allow these inflammatory responses to decrease and facilitate cell polarization into a distinct M2-like phenotype21.

This protocol demonstrates a method to differentiate and polarize THP-1 monocyte-like cells into an M2-like phenotype of macrophages within 14 days.

Protocol

NOTE: An overview of the steps described in this protocol is shown in Figure 1. The human monocyte-like leukemia cell line THP-1 was purchased. Short tandem repeat analysis was performed to authenticate the THP-1 cell line. Perform all steps under sterile conditions. The THP-1 monocytic cell line grows in suspension and does not attach to cell culture surfaces. Adherence can be induced by differentiating monocytes into macrophage-like cells through, e.g., mechanical stress or specific treatment with PMA.

1. Culturing and maintenance of THP-1 monocyte-like cells

  1. Set a timer for 150 s. Remove the frozen vial containing the THP-1 cell line (Table of Materials) from the liquid nitrogen and thaw it immediately in a clean water bath (37 °C). Start the timer as soon as the vial is put into the water bath. Loosen the cap to release the pressure that is building up due to the thawing process but ensure that the tube opening does not contact the water, to avoid contamination. The optimal time period for thawing the cells lies between 120-150 s. Continue thawing the cell suspension until an ice chip of the size of about 4 mm is left within the vial; then, proceed to the next step immediately.
  2. Transfer the liquid phase of the cell suspension to a 15 mL tube containing 9 mL of warm (37 °C) growth media (Table of Materials). Then, transfer 1 mL of the warm medium-cell suspension into the THP-1 vial and back into the 15 mL tube to melt the remaining ice chip and flush the vial to assure that no cells are left behind.
  3. Mix the suspension gently by pipetting up and down with a 1000 µL pipette. Remove a small sample (approximately 10 µL) to count the cells for viability (using trypan blue for exclusion) while they are spun. Spin down the warm cell suspension at 200 x g for 7 min at 37 °C.
  4. Remove the supernatant completely and resuspend with a certain volume of warm growth medium to achieve a cell density of 5 x 105/mL. Mix the suspension gently and transfer 22 mL of volume into T-75 cell culture flasks (Table of Materials). Store flasks upright in an incubator at 37 °C with 5% carbon dioxide (CO2) concentration. Exchange the growth media every 3-4 days.

2. Seeding of THP-1 cells and differentiation into M0 macrophages

  1. Prepare the cell containing growth medium with the respective cell density to seed cells at a density of 3 x 105/mL/well into 24-well cell culture plates (Table of Materials). Mix the medium gently and prepare aliquots of 26 mL, each put into a 50 mL tube. Use each 26 mL aliquot for seeding the cells into a respective plate.
  2. Transfer 1 mL of the cell-containing medium into each well of a 24-well plate. Mix the media gently by pipetting up and down between transfers.
  3. Prepare a stock solution of PMA (dissolve 1 mg of PMA in 100 µL of Dimethyl Sulfoxide (DMSO) = ~16 mM solution of PMA in DMSO) and dilute it with cold Phosphate Buffered Saline (PBS) to a final working concentration of 10 ng/µL right before cell treatment (Table of Materials). Keep the solution on ice and use it immediately. Do not refreeze. Add 100 ng of PMA per well. Let each cell plate sit in the incubator without any further treatment for 72 h.
  4. After 72 h, remove the growth medium and replace it with 1 mL of fresh growth medium. Do not touch the bottom of the wells with pipette tips. Let the cells rest for another 96 h in the incubator.
  5. After 96 h, repeat step 2.4 (media change) and let the cells rest for another 24 h.
    ​NOTE: The M0 macrophages are now ready to be used for experiments (Figure 2). Immediately prior to treating the cells as part of further experiments, consider a media change with RPMI only (Table of Materials) since growth media supplements can cause interference with reagents that are added for cell treatment. In case M2-like macrophages are needed, proceed with section 3.

3. Polarization of M0 macrophages into M2-like macrophages

  1. Prepare a stock solution of IL-4 and IL-13 (dissolve 20 µg of IL-4 or IL-13 in 200 µL of nuclease-free water) and dilute it to a final working concentration of 2 ng/µL with PBS immediately prior to cell treatment. Keep the solution on ice and use it immediately. Do not refreeze.
  2. Remove the growth medium and replace it with 1 mL of fresh growth medium. Add 20 ng of interleukin 4 (IL-4) and 20 ng of interleukin 13 (IL-13) per well. Let the cells rest for 48 h in the incubator.
  3. After 48 h, repeat step 3.2. Let the cells rest for another 48 h in the incubator.
  4. Remove the growth medium and replace it with 1 mL of fresh growth medium. Let the cells rest for 48 h in the incubator.
    NOTE: M2-like macrophages are now ready to be used for experiments (Figure 2). Immediately prior to treating the cells as part of further experiments, consider a media change with RPMI only (Table of Materials) since growth media supplements can cause interference.

4. Detaching and harvesting macrophages for flow cytometry

NOTE: Use a mechanical method combining cold shocking and cell scraping to detach and harvest the polarized macrophages from plates for flow cytometry.

  1. Remove the warm cell medium and replace it with a mixture of ice-cold PBS (without calcium and magnesium) and 5% fetal bovine serum (FBS), 1 mL per well. Immediately after this, place the cell plate on ice for 45 min. Do not place the cell plate on ice before the warm cell medium is removed, since this will decrease cell viability significantly. Keep the cells on ice only after inducing cold shock with ice-cold PBS/5% FBS mixture.
  2. After 45 min on ice, scrape off the cells using mini cell scrapers (Table of Materials). Gently transfer the detached macrophages in cold PBS/5% FBS into a 15 mL tube. Keep the tube on ice at all times until cells are stained.
    NOTE: Pool eight wells of cells to reach adequate cell counts for staining.

Results

M2-like macrophages were characterized, and M2-polarization was validated using flow cytometry for Cluster of Differentiation markers (CD) CD14, CD11b, CD80 (M1-like marker), and CD206 (M2-like marker). Flow cytometry staining was performed according to the manufacturer's instructions. Macrophages were washed with PBS/5% FBS and incubated with Fcγ-receptor block to avoid unspecific binding. Cells were then stained with FITC-conjugated mouse anti-human CD14 and CD80 antibodies, with PE-conjugated mouse anti-human...

Discussion

This protocol on differentiating and polarizing THP-1 monocyte-like cells within 14 days provides a method to obtain macrophages with a distinct M2-like phenotype due to long treatment incubation of cells with adequate resting periods between steps.

Certain steps are critical to this protocol. The doubling time of THP-1 monocytes is approximately 26 h. Cells can be split at a cell density of 9 x 105/mL and should be seeded at a density of 3 x 105/mL during every split. Th...

Disclosures

The authors declare no potential conflicts of interest.

Acknowledgements

The Price Institute of Surgical Research, University of Louisville, is financially supported by the John W. Price and Barbara Thruston Atwood Price Trust. The funding sources had no role in the design and conduct of the study as well as in the collection, management, analysis, and interpretation of the data.

Materials

NameCompanyCatalog NumberComments
0.4% trypan blueVWR, Radnor, USA152-5061
1.5 mL microcentrifuge tubeUSA Scientific, Ocala, USA1615-5510
10 mL serological pipetVWR, Radnor, USA 89130-898
1000 μL TipOne pipet tipsUSA Scientific, Ocala, USA1111-2821
15 mL  Centrifuge tubeVWR, Radnor, USA89039-664
20 μL TipOne pipet tipsUSA Scientific, Ocala, USA1120-1810
200 μL TipOne pipet tipsUSA Scientific, Ocala, USA1120-8810
25 mL serological pipetVWR, Radnor, USA 89130-900
5 mL serological pipetVWR, Radnor, USA 89130-896
50 mL Centrifuge tubeVWR, Radnor, USA89039-662
Accutase solution 500 mLSigma, St. Louis, USAA6964
Antibiotic Antimycotic Solution (100x), stabilizedSigma, St. Louis, USAA5955-100 mLwith 10,000 units penicillin, 10 mg of streptomycin and 25 μg of amphotericin B per mL, sterile-filtered, BioReagent, suitable for cell culture
Binder CO2 IncubatorVWR, Radnor, USAC170-ULE3
CytoOne T-75cm flask with filter capUSA Scientific, Ocala, USACC7682-4875
Dulbecco’s Phosphate Buffered Saline (PBS)Sigma, St. Louis, USAD8537-500 mLPBS without calcium chloride and magnesium chloride should be used, since both can alter macrophage polarization
Eppendorf Centrifuge 5804 R (refrigerated)Eppendorf, Enfield, USA-
Ethyl alcohol (70%)--
FACSCalibur flow cytometerBD Biosciences, San Diego, USA-The flow cytometer operates with CellQuest software (BD Biosciences)
Falcon 24-well plateVWR, Radnor, USA353504
Fetal Bovine Serum (FBS)ATCC, Manassas, USA30-2020
FITC Mouse Anti-Human CD14BD Biosciences, San Diego, USA555397Flow cytometry, myeloid cell marker (100 tests)
FITC Mouse Anti-Human CD80BD Pharmingen, San Diego, USA557226Flow cytometry, M1 marker (100 tests)
FITC Mouse IgG1 κ Isotype ControlBD Pharmingen, San Diego, USA555748Flow cytometry, isotype control for CD80 (100 tests)
FITC Mouse IgG2a, κ Isotype ControlBD Biosciences, San Diego, USA553456Flow cytometry, isotype control for CD14 (100 tests)
Human BD Fc BlockBD Biosciences, San Diego, USA564220Flow cytometry, Fc block (0.25 mg)
Human interleukin 13 (IL-13)R&D, Minneapolis, USAIL-771-10 μg
Human interleukin 4 (IL-4)R&D, Minneapolis, USASRP3093-20 μg
Labconco Biosafety Cabinet (Delta Series 36212/36213)Labconco, Kansas City, USA-
L-Glutamine Solution, 200 mMATCC, Manassas, USA30-2214
Lipopolysaccharide (LPS) from E. coli 0111:B4Sigma, St. Louis, USAL2630-100 mg
Mini Cell ScrapersBiotium, Fremont, USA22003
Neubauer hemocytometerFisher Scientific, Waltham, USA02-671-5
Nikon Eclipse inverted microscope TS100Nikon, Melville, USA-
Nuclease-free waterInvitrogen, Carlsbad, USAAM9937
Olympus Light Microscope RH-2Microscope Central, Feasterville, USA40888
P10 variable pipet- GilsonVWR, Radnor, USA76180-014
P1000 variable pipet-GilsonVWR, Radnor, USA76177-990
P200 variable pipet- GilsonVWR, Radnor, USA76177-988
PE Mouse Anti-Human CD11bBD Biosciences, San Diego, USA555388Flow cytometry, myeloid cell marker (100 tests)
PE Mouse IgG1, κ Isotype ControlBD Biosciences, San Diego, USA555749Flow cytometry, isotype control for CD11b (100 tests)
PE-Cy 5 Mouse Anti-Human CD206BD Pharmingen, San Diego, USA551136Flow cytometry, M2 marker (100 tests)
PE-Cy 5 Mouse IgG1 κ Isotype ControlBD Pharmingen, San Diego, USA555750Flow cytometry, isotype control for CD206 (100 tests)
Phorbol 12-myristate 13-acetate (PMA)Sigma, St. Louis, USAP8139
Powerpette Plus pipettorVWR, Radnor, USA75856-448
Precision Water bath (model 183)Precision Scientific, Chicago, USA66551
RPMI-1640 MediumATCC, Manassas, USA30-2001
THP-1 cell line, American Type Culture Collection (ATCC)ATCC, Manassas, USATIB-202

References

  1. Zhang, R., et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Cell Death and Disease. 10 (4), 273 (2019).
  2. Wang, J., Li, D., Cang, H., Guo, B. Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Cancer Medicine. 8 (10), 4709-4721 (2019).
  3. Soncin, I., et al. The tumor microenvironment creates a niche for the self-renewal of tumor-promoting macrophages in colon adenoma. Nature Communications. 9 (1), 582 (2018).
  4. Mosser, D. M., Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 8 (12), 958-969 (2008).
  5. Mazzone, M., Menga, A., Castegna, A. Metabolism and TAM functions-it takes two to tango. Federation of European Biochemical Societies Journal. 285 (4), 700-716 (2018).
  6. Eum, H. H., et al. Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer. Experimental and Molecular Medicine. 52 (12), 1976-1988 (2020).
  7. Qian, B. Z., Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell. 141 (1), 39-51 (2010).
  8. Scheurlen, K. M., Billeter, A. T., O'Brien, S. J., Galandiuk, S. Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge. Cancer Medicine. 9 (18), 6679-6693 (2020).
  9. Bosshart, H., Heinzelmann, M. THP-1 cells as a model for human monocytes. Annals of Translational Medicine. 4 (21), 438 (2016).
  10. . The American Type Culture Collection (ATCC) Available from: https://www.atcc.org/products/all/TIB-202.aspx#generalinformation (2021)
  11. Baxter, E. W., et al. Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNgamma+LPS), M(IL-4), and M(IL-10) phenotypes. Journal of Immunological Methods. 478, 112721 (2020).
  12. Genin, M., Clement, F., Fattaccioli, A., Raes, M., Michiels, C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 15, 577 (2015).
  13. Starr, T., Bauler, T. J., Malik-Kale, P., Steele-Mortimer, O. The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium. PLoS One. 13 (3), 0193601 (2018).
  14. Lund, M. E., To, J., O'Brien, B. A., Donnelly, S. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. Journal of Immunological Methods. 430, 64-70 (2016).
  15. Yin, Z., et al. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Journal of Cellular Biochemistry. 119 (11), 9419-9432 (2018).
  16. O'Neill, L. A. J., Artyomov, M. N. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nature Reviews Immunology. 19 (5), 273-281 (2019).
  17. Luig, M., et al. Inflammation-induced IL-6 functions as a natural brake on macrophages and limits gn. Journal of the American Society of Nephrology. 26 (7), 1597-1607 (2015).
  18. Maruyama, K., Nemoto, E., Yamada, S. Mechanical regulation of macrophage function - cyclic tensile force inhibits NLRP3 inflammasome-dependent IL-1beta secretion in murine macrophages. Inflammation and Regeneration. 39, 3 (2019).
  19. Gatto, F., et al. PMA-Induced THP-1 Macrophage Differentiation is Not Impaired by Citrate-Coated Platinum Nanoparticles. Nanomaterials (Basel). 7 (10), (2017).
  20. Maess, M. B., Wittig, B., Cignarella, A., Lorkowski, S. Reduced PMA enhances the responsiveness of transfected THP-1 macrophages to polarizing stimuli. Journal of Immunological Methods. 402 (1-2), 76-81 (2014).
  21. Daigneault, M., Preston, J. A., Marriott, H. M., Whyte, M. K., Dockrell, D. H. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 5 (1), 8668 (2010).
  22. Raggi, F., et al. Regulation of human macrophage M1-M2 polarization balance by hypoxia and the triggering receptor expressed on myeloid cells-1. Frontiers in Immunology. 8, 11097 (2017).
  23. Neutelings, T., Lambert, C. A., Nusgens, B. V., Colige, A. C. Effects of mild cold shock (25 degrees C) followed by warming up at 37 degrees C on the cellular stress response. PLoS One. 8 (7), 69687 (2013).
  24. Kurashina, Y., et al. Enzyme-free release of adhered cells from standard culture dishes using intermittent ultrasonic traveling waves. Communications Biology. 2, 393 (2019).
  25. Chen, S., So, E. C., Strome, S. E., Zhang, X. Impact of Detachment Methods on M2 Macrophage Phenotype and Function. Journal of Immunological Methods. 426, 56-61 (2015).
  26. Bailey, J. D., et al. Isolation and culture of murine bone marrow-derived macrophages for nitric oxide and redox biology. Nitric Oxide. 100-101, 17-29 (2020).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Macrophage DifferentiationTHP 1 CellsM2 like PhenotypeAnti inflammatory MacrophagesCancer PrognosisCell Culture ProtocolPolarization ProcessColon CancerTissue RemodelingViable Cell CountGrowth MediaCell Density

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved